| Trial ID: | L1033 |
| Source ID: | NCT00261625
|
| Associated Drug: |
Alendronate
|
| Title: |
Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease|Osteoporosis
|
| Interventions: |
DRUG: alendronate
|
| Outcome Measures: |
Primary: extent of aortic and coronary artery calcification with and without the use of alendronate|bone mineral density with and without the use of alendronate | Secondary: serum levels of calcium, phosphorus and parathyroid hormone
|
| Sponsor/Collaborators: |
Sponsor: National Taiwan University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-08
|
| Completion Date: |
2007-10
|
| Results First Posted: |
|
| Last Update Posted: |
2009-01-05
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00261625
|
